Product Pathways
BCP0008 GSK690693
aminofurazan-derived inhibitor of Akt kinases with potential antine
BCP0075 MK2206
MK-2206, a highly selective non-ATP competitive allosteric Akti, has nM IC50 and broad preclinical antitumor activity.
BCP0095 Perifosine
Perifosine is a novel Akt inhibitor with IC50 of 4.7 μM.
BCP0127 Triciribine
Triciribine/API-2 is a synthetic tricyclic nucleoside, triciribine/API-2 acts as a specific inhibitor of the Akt signaling pathway.
BCP0158 Dapagliflozin(BMS-512148)
Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM.
BCP0213 Akt-l-1
Akt-I-1 is an Akt kinase inhibitor with isoenzyme specificity for Akt1 (IC50 4.6nM).
BCP000648 PIT 1
PIT 1,a selective PIP3 antagonist.
BCP000729 AT7867
AT7867 is a potent and oral AKT and p70 S6 kinase inhibitor with an IC50 of 17 nM.
BCP000798 Palomid 529 (P529)
BCP000851 Canagliflozin
Canagliflozin is a highly potent and selective SGLT2 inhibitor for CHO-hSGLT2, CHO-rSGLT2 and CHO-mSGLT2 with IC50 of 4.4 nM, 3.7 nM and 2 nM, respectively.
第一页 1 2 3 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.